- Home
- SGML vs AVTX Comparison
SGML vs AVTX Comparison
Compare SGML & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGML | AVTX |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 982.5M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SGML | AVTX |
|---|---|---|
| Price | $11.74 | $19.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $18.75 | ★ $40.57 |
| AVG Volume (30 Days) | ★ 1.5M | 820.3K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | $272.11 | N/A |
| Revenue Next Year | $36.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $4.62 | $8.41 |
| 52 Week High | $24.48 | $24.27 |
Technical Indicators
Market Signals| Indicator | SGML | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 57.81 |
| Support Level | $11.16 | $17.32 |
| Resistance Level | $12.36 | $20.68 |
| Average True Range (ATR) | 0.59 | 1.22 |
| MACD | 0.34 | -0.05 |
| Stochastic Oscillator | 94.54 | 89.23 |
Price Performance
Historical ComparisonAbout SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.